Drug
Enoxaparin Placebo
Enoxaparin Placebo is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_4
1
25%
Ph phase_3
2
50%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
NCT00571649
completedphase_3
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00371683
unknownphase_4
Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage
NCT00699465
completedphase_2
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
NCT00097357
Clinical Trials (4)
Showing 4 of 4 trials
NCT00571649Phase 3
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
NCT00371683Phase 3
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00699465Phase 4
Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage
NCT00097357Phase 2
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4